I'm seriously not here to hurt of manipulate this board. I had asked NTEK a while back but they declined at that point in time. I'm hoping now they may react differently! Be a huge boost for shareholders in my opinion and others who may be lurking
Thank You dennyd! I'm seriously not here to hurt of
I'm seriously not here to hurt of manipulate this board. I had asked NTEK a while back but they declined at that point in time. I'm hoping now they may react differently! Be a huge boost for shareholders in my opinion and others who may be lurking
Top 10 Most Recent News Articles
Quantum Space Joins $185M NASA Lunar Transport Deal
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate
Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...
Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
2027 Toy of the Year Finalists Energize Play Market
A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...
Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue ReadingTop 5 Most Recently Viewed Articles
Hanwha Power Systems Leads Green Transition in Shipping Industry
Hanwha Power Systems Secures Approval for Ammonia Retrofit In a groundbreaking development, Hanwha Power Systems has achieved Approval in Principle (AiP) from the American Bureau of Shipping (ABS) for a pioneering ammonia fuel gas turbine conversion design. This crucial step targets the retrofitting of 174K LNG carriers and showcases a commitment to eco-friendly maritime...
Continue Reading
Titomic's Strategic Innovations Set for Future Growth
Titomic's Growth Journey and Strategic Innovations Titomic Limited (ASX: TTT), a leading player in advanced additive manufacturing, has recently released its Annual Report detailing a transformational year. While the specifics might be under wraps, the overarching narrative showcases a commitment to innovation and strategic growth. FY2025 Report Highlights The company has...
Continue Reading
Evogene's Challenges Lead to 52-Week Low: Future Outlook
Evogene Ltd. Stock Performance and Recent Developments Amid ongoing challenges in the market, Evogene Ltd. (NASDAQ: EVGN) has hit a notable 52-week low, dipping to a price of $2.21. This agricultural biotechnology company is dedicated to advancing product development through computational biology. Over the past year, its stock performance has reflected a downward trend,...
Continue Reading
Explore Ancient Egyptian Innovations at Nile University Lecture
Explore Ancient Egyptian Innovations at Nile University Lecture Founder Of Nile University Exposes Misattributed Egyptian Innovations In an exciting event, Nile University (NU), renowned as Egypt's first national, non-profit university focused on excellence in technology and business education, is thrilled to announce an upcoming lecture. The distinguished speaker for...
Continue Reading
MGP Ingredients, Inc. Faces Class Action: Key Dates and Details
MGP Ingredients, Inc. Faces Class Action Lawsuit The Gross Law Firm is announcing a class action lawsuit that impacts shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI). This notice is aimed at informing shareholders who acquired shares during a specified class period about the opportunity to get involved in the lawsuit. Why Should Shareholders Consider Participating?...
Continue Reading